Publication:
Prevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study.

cris.virtualsource.author-orcidde157b00-7a90-4024-9ae4-fbb16f98b209
datacite.rightsopen.access
dc.contributor.authorOraii, Alireza
dc.contributor.authorShafiee, Akbar
dc.contributor.authorJalali, Arash
dc.contributor.authorAlaeddini, Farshid
dc.contributor.authorSaadat, Soheil
dc.contributor.authorMasoudkabir, Farzad
dc.contributor.authorVasheghani-Farahani, Ali
dc.contributor.authorHeidari, Amirhossein
dc.contributor.authorSadeghian, Saeed
dc.contributor.authorBoroumand, Mohamamdali
dc.contributor.authorKarimi, Abbasali
dc.contributor.authorFranco Duran, Oscar Horacio
dc.date.accessioned2024-10-11T17:25:35Z
dc.date.available2024-10-11T17:25:35Z
dc.date.issued2022-10-17
dc.description.abstractBACKGROUND The prevalence of type 2 diabetes mellitus has increased in the past decades. We investigated the prevalence of diabetes and its awareness, treatment, and control among adult residents of Tehran. METHODS We used the recruitment phase data of the Tehran Cohort study, enrolling a random sample of adult residents of Tehran aged ≥35 years. Diabetes was defined as self-report, current use of glucose-lowering medications, and/or fasting plasma glucose (FPG) ≥126mg/dl. Impaired fasting glucose (IFG) was defined as an FPG of 100-125mg/dl. Awareness was defined as diabetes self-report, treatment as receiving glucose-lowering medications, and glycemic control as FPG <126mg/dl. The age- and sex-weighted estimates were calculated using the 2016 national census. Logistic regression models were used to determine the factors associated with diabetes awareness, treatment, and control. RESULTS A total of 8151 participants were included. Age- and sex-weighted prevalence of diabetes mellitus and IFG were 16.7% (95% CI: 15.1-18.4) and 25.1% (95% CI: 23.1-27.1), respectively. Diabetes was more prevalent in the eastern and central districts of Tehran. Advanced age (OR per 1-year increase: 1.026, 95% CI: 1.021-1.030), male sex (OR: 1.716, 95% CI: 1.543-1.909), higher BMI levels (OR for BMI ≥35 vs. <20 kg/m2: 4.852, 95% CI: 3.365-6.998), pre-existing hypertension (OR: 1.552, 95% CI: 1.378-1.747), dyslipidemia (OR: 1.692, 95% CI: 1.521-1.883), and chronic kidney disease (OR: 1.650, 95% CI: 1.019-2.673) were associated with an increased odds of diabetes mellitus. On the contrary, diabetes mellitus was less likely in current tobacco (OR: 0.872, 95% CI: 0.765-0.994) and alcohol users (OR: 0.836, 95% CI: 0.703-0.994) compared to non-users. Among diabetic individuals, 82.8% were aware of their condition, 71.9% received treatment, and 31.7% of treated patients had adequate glycemic control. Advanced age and pre-existing comorbidities, including hypertension and dyslipidemia, were associated with higher diabetes awareness and treatment. Furthermore, advanced age, higher levels of education, and female sex were determinants of better glycemic control among treated diabetic participants. CONCLUSION There is a high prevalence of diabetes and IFG among adult residents of Tehran. Additionally, more than two-thirds of treated diabetics living in Tehran remain uncontrolled.
dc.description.numberOfPages15
dc.description.sponsorshipInstitut für Sozial- und Präventivmedizin (ISPM)
dc.identifier.doi10.48350/173899
dc.identifier.pmid36253738
dc.identifier.publisherDOI10.1186/s12902-022-01161-w
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/88201
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofBMC Endocrine Disorders
dc.relation.issn1472-6823
dc.relation.organizationInstitute of Social and Preventive Medicine
dc.subjectAwareness Control Diabetes mellitus Epidemiology Prevalence Treatment
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc300 - Social sciences, sociology & anthropology::360 - Social problems & social services
dc.titlePrevalence, awareness, treatment, and control of type 2 diabetes mellitus among the adult residents of tehran: Tehran Cohort Study.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.issue1
oaire.citation.startPage248
oaire.citation.volume22
oairecerif.author.affiliationInstitut für Sozial- und Präventivmedizin (ISPM)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2022-10-19 11:12:28
unibe.description.ispublishedpub
unibe.eprints.legacyId173899
unibe.journal.abbrevTitleBMC ENDOCRIN DISORD
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
s12902-022-01161-w.pdf
Size:
1.42 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections